Lv7
4990 积分 2023-10-08 加入
Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone alone in newly diagnosed multiple myeloma (MAIA): overall survival results from a randomised, open-label, phase 3 trial
1小时前
已完结
Revisiting the role of alkylating agents in multiple myeloma: Up-to-date evidence and future perspectives
27天前
已完结
Addition of High-Dose Cytarabine to Fludarabine, Busulfan, and Melphalan Conditioning for Cord Blood Transplantation in Adult Acute Myeloid Leukemia
29天前
已完结
Impact of daratumumab on the development of engraftment syndrome after autologous peripheral blood stem cell transplantation for multiple myeloma
29天前
已完结
Opening the Door to Tailored Treatment in Newly Diagnosed Multiple Myeloma
1个月前
已完结
Opening the Door to Tailored Treatment in Newly Diagnosed Multiple Myeloma
1个月前
已完结
Integration of venetoclax into a fludarabine and melphalan conditioning regimen in patients aged 50 years and older with acute myeloid leukemia and myelodysplastic syndrome: Results from a phase 2 clinical trial
1个月前
已完结
Busulfan, etoposide, cytarabine, and melphalan as a high-dose regimen for autologous stem cell transplantation in peripheral T-cell lymphomas
1个月前
已完结
Busulfan, etoposide, cytarabine, and melphalan (BuEAM) as a conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma (NHL)
1个月前
已完结
Incidence, mortality, and survival associated with acute leukaemia subtypes by age group in China: a population-based cancer registry analysis and cohort study
1个月前
已完结
皖公网安备34019202002308
